Key Record Dates Identifier: NCT01492361
Brief Title: A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event. (REDUCE-IT)

First Submitted : December 13, 2011
First Submitted that Met QC Criteria : December 13, 2011
First Posted : December 15, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : October 12, 2018
Last Update Posted : October 16, 2018